Case number 1:18-cv-01762
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Alembic Pharmaceuticals Ltd. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 28, 2021 | N/A | Terminated Case (0) Docket Text: CASE CLOSED per the filing of the Consent Judgment in Lead Case No. 18-1689-CFC. (nmf) |
| Apr 23, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Andrew C. Ryan for Alembic Pharmaceuticals Ltd. and Alembic Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (amf) |
| Apr 22, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorneys Nicholas A. Geiger and Steven M. Coyle for Alembic Pharmaceuticals Ltd. and Alembic Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (amf) |
| Mar 5, 2019 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Magistrate Judge Sherry R Fallon for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at http://www.ded.uscourts.gov/general-orders/magistrate-judges-standing-order-adr-mediation Associated Cases: 1:18-cv-01689-CFC-SRF et al.(cak) |
| Mar 5, 2019 | N/A | Create Case Association (0) Docket Text: Case associated with lead case: Create association to 1:18-cv-01689-CFC-SRF. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE 18-1689-CFC ONLY. (nmf) |
| Mar 5, 2019 | 17 | Scheduling Order (21) Docket Text: SCHEDULING & CONSOLIDATION ORDER: These actions are consolidated for all purposes and all papers shall be filed in Lead Case No. 18-1689-CFC. Case referred to the Magistrate Judge for the purpose of exploring ADR. Case referred to the Magistrate Judge for all disputes relating to discovery matters and protective orders. Joinder of Parties due by 4/30/2020. Amended Pleadings due by 4/30/2020. Fact Discovery completed by 3/22/2020. Joint Claim Construction Brief due by 2/28/2020. A Markman Hearing is set for 4/7/2020 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. A Final Pretrial Conference is set for 4/8/2021 at 04:00 PM in Courtroom 4B before Judge Colm F. Connolly. A Bench Trial is set for 4/19/2021 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 3/4/2019. Associated Cases: 1:18-cv-01689-CFC et al.(nmf) |
| Mar 4, 2019 | N/A | Scheduling Conference (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Scheduling Conference held on 3/4/2019. (Court Reporter V. Gunning.) Associated Cases: 1:18-cv-01689-CFC et al.(nmf) |
| Feb 28, 2019 | N/A | Set/Reset Hearings (0) Docket Text: Reset Hearings: The Scheduling Conference on 3/4/2019 at 02:30 PM before Judge Colm F. Connolly is rescheduled as a Telephonic Scheduling Conference per the letter and proposed scheduling order filed today stating that there are no areas of dispute. Associated Cases: 1:18-cv-01689-CFC et al.(nmf) |
| Feb 28, 2019 | 16 | Proposed Order (21) Docket Text: PROPOSED ORDER -- [Proposed] Scheduling Order -- by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Attachments: # (1) Letter to The Honorable Colm F. Connolly)(Egan, Brian) |
| Feb 28, 2019 | 16 | Letter to The Honorable Colm F. Connolly (2) |
| Feb 12, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [14] MOTION for Pro Hac Vice Appearance of Attorney Steven M. Coyle, Nicholas A. Geiger, and Andrew C. Ryan filed by Alembic Pharmaceuticals Ltd., Alembic Pharmaceuticals, Inc. Signed by Judge Colm F. Connolly on 2/12/2019. (fms) |
| Feb 12, 2019 | 15 | Answer to Counterclaim (13) Docket Text: ANSWER to [12] Answer to Complaint,, Counterclaim, -- Plaintiffs' Answer to Alembic Pharmaceuticals Ltd. and Alembic Pharmaceuticals, Inc.'s Counterclaims -- by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Egan, Brian) |
| Feb 11, 2019 | 14 | Motion for Leave to Appear Pro Hac Vice (5) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Steven M. Coyle, Nicholas A. Geiger, and Andrew C. Ryan - filed by Alembic Pharmaceuticals Ltd., Alembic Pharmaceuticals, Inc.. (Farnan, Kelly) |
| Jan 22, 2019 | 12 | Answer to Complaint (21) Docket Text: ANSWER to [1] Complaint, , COUNTERCLAIM against Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc. by Alembic Pharmaceuticals, Inc., Alembic Pharmaceuticals Ltd..(Farnan, Kelly) |
| Jan 22, 2019 | 13 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Alembic Global Holdings S/A for Alembic Pharmaceuticals Ltd., Alembic Pharmaceuticals, Inc. filed by Alembic Pharmaceuticals Ltd., Alembic Pharmaceuticals, Inc.. (Farnan, Kelly) |
| Jan 3, 2019 | 11 | Order Setting Scheduling Conference (9) Docket Text: Order Setting Scheduling Conference: A Scheduling Conference is set for 3/4/2019 at 02:30 PM in Courtroom 4B before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 1/3/2019. Associated Cases: 1:18-cv-01689-CFC et al.(nmf) |
| Dec 28, 2018 | 10 | Letter (2) Docket Text: Letter to The Honorable Colm F. Connolly from Jack B. Blumenfeld regarding coordinated discovery and Markman proceedings, and to request a scheduling conference. (Blumenfeld, Jack) |
| Dec 17, 2018 | 9 | Order (8) Docket Text: ORDER, IT IS ORDERED that, on or before January 2, 2019, counsel for plaintiffs shall inform the court as to whether the need for coordinated discovery and/or Markman proceedings is anticipated as to the above cases and, if so, when a joint scheduling conference might most efficiently be conducted. ORDER, Setting Deadlines: ( Notice of Compliance deadline set for 1/2/2019.) Signed by Judge Colm F. Connolly on 12/17/2018. Associated Cases: 1:18-cv-01689-CFC et al.(nmf) |
| Nov 30, 2018 | 7 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, Boehringer Ingelheim Corporation: For Alembic Pharmaceuticals Ltd. waiver sent on 11/21/2018, answer due 1/22/2019. (Blumenfeld, Jack) |
| Nov 30, 2018 | 8 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, Boehringer Ingelheim Corporation: For Alembic Pharmaceuticals, Inc. waiver sent on 11/21/2018, answer due 1/22/2019. (Blumenfeld, Jack) |
| Nov 20, 2018 | 6 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, Boehringer Ingelheim Corporation. Alembic Pharmaceuticals, Inc. served on 11/20/2018, answer due 12/11/2018. (Blumenfeld, Jack) |
| Nov 14, 2018 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. Associated Cases: 1:18-cv-01757-CFC, 1:18-cv-01758-CFC, 1:18-cv-01762-CFC through 1:18-cv-01765-CFC, 1:18-cv-01779-CFC, 1:18-cv-01783-CFC, and 1:18-cv-01785-CFC through 1:18-cv-01789-CFC (rjb) |
| Nov 9, 2018 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Alembic Pharmaceuticals Ltd. on 11/9/2018; Alembic Pharmaceuticals, Inc. on 11/9/2018. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (nmg) |
| Nov 8, 2018 | 1 | Exhibit 1-2 (58) |
| Nov 8, 2018 | 1 | Civil Cover Sheet (1) |
| Nov 8, 2018 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg) |
| Nov 8, 2018 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 9/28/2018. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 2/1/2022. (nmg) |
| Nov 8, 2018 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,713,938 B2; 9,949,998 B2. (nmg) |
| Nov 8, 2018 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate C. H. Boehringer Sohn AG & Co. KG. for Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc. filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc. (nmg) |
